Transcode Therapeutics, Inc.
For the period ended Dec 31, 2025. Filed Apr 15, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Apr 15, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
As of December 31, 2025, we conducted the majority of our R&D activities in conjunction with Michigan State University with which we recently entered a sponsored research agreement. We moved our business operations into office space in Woburn, Massachusetts, under a short-term rental arrangement. We maintain a “virtual office” at the address set forth on the cover page of this Annual Report. We also rent office space in Boca Raton, Florida.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.